Different techniques for needleless injection, where the force is generated by a coil spring, compressed gas, a piezo element, or ultimately, a laser.
Fear of needles is a reason for some people not to be vaccinated against Covid-19. That fear is of all times: it is not without reason that different techniques have been developed for more than 150 years for injecting without a needle. The technique that is now being developed by UT scientist David Férnandez Rivas and his team has become increasingly safer. And the way to give the injection fluid speed is more precise to control as well as the penetration depth in the body. Reason enough for his PhD student Jelle Schoppink to compare the various options in a ‘perspective paper’ in the authoritative Advanced Drug Delivery Reviews .
The needle-free injection, which uses a liquid jet that is heated and propelled by a laser, is a development that is in full swing at the UT and has also led to the foundation of the company FlowBeams. Being able to inject or tattoo without needles is a promising development: it removes barriers for people and also reduces the large mountain of medical waste. It is also important that the fluid jet is easily controllable: do not use more fluid than is necessary, and also dose at a shallow depth below the skin surface.
“There is growing evidence that it is important to deliver small volumes directly below the skin’s surface, that is in the dermis and epidermis. We are able to do this with laser-guided injection.”
Jelle Schoppink, researcher needle-free injection
That control was different during the needle-free mass vaccination in the mid- 20th century. The liquid got its propulsion thanks to a compressed and released spring. The penetration depth, at 2 to 10 millimeters, was large and not easy to control. When it also turned out that part of the blood came back into the injector and could thus infect others, the World Health Organization (WHO) put an end to this method of injecting.
The application of lasers seems to be the most promising in the last ten years, after experiments with, among other things, compressed gas and piezoelectric power transmission. The Physics of Fluids group of Detlef Lohse and Michel Versluis started at the University of Twente with laser-guided jets, using a so-called pulsed laser. The group of David Fernández Rivas now opts for a continuous laser. Among other things, the lower costs of the laser play a role in this. The control over the fluid dynamics is great in both cases: not only is there no injection fluid wasted, it is quite possible to inject precisely into the dermis or epidermis. The typical depth is then 0.1 millimeter to 1 millimeter. The fact that the injection liquid is heated by the laser does not seem to affect the performance negatively.
Also, given the issues with early techniques, it is quite possible to prevent jet firing back. Although the technique has not yet been tested on humans, tests on gels that resemble human skin and on pig skin look good. Although the nozzle still needs to be replaced at the moment, Schoppink estimates that this will no longer be necessary in the long term, so that the amount of waste is kept to a minimum.
This means that the injection with needles is not completely off the table. An alternative to completely needle-free injection is the use of microneedles that the UT has also worked on and that are manufactured with silicon technology. You hardly feel them, like a kind of sandpaper, and can also be used at a shallow depth and precisely. In combination with the laser-guided liquid jet, the microneedles could serve as a kind of ‘signpost’ for very precise administration in different places at the same time.
The broad ‘perspective’ article by Jelle Schoppink therefore not only provides the history and the current playing field with his competitors, but also explores the possibilities of combining techniques.
Original Article: FROM COIL SPRING TO LASER: NEEDLE-FREE INJECTION INCREASINGLY PRECISE
More from: University of Twente
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Global Needle Free Injection System Market Report…
The "Global Needle Free Injection System Market to 2027: Trends, Opportunities and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.The global needle-free injection ...
- Needle-Free Injection Device Market Insights, Competitional Analysis within Top Players 2026
The MarketWatch News Department was not involved in the creation of this content. Feb 02, 2023 (The Expresswire) -- [Report Pages- 109]Needle-Free Injection Device Market size is expected to reach ...
- Botox in a bottle? These skin care products deliver
While many aren’t worth a second thought, the “ Botox in a bottle ” videos left us wanting to know more. Though we’re in full support of people heading to an expert for whatever cosmetic treatments ...
- Needles to say, Ghostline drags tattoo stencil making 'inkto' the current millennium
The company currently has around 3,000 users, growing at around 100 per day. It's free to try for a week; after that, it costs $5.99 per month or $59.99 per year for unlimited use. InkHunter heads to ...
- A needle-free injection for diabetics
A needle-free injection will soon be available to thousands of diabetics. A British company has designed a £120 gadget that could free diabetics from the daily trauma of painful injections.
Go deeper with Google Headlines on:
[google_news title=”” keyword=”needle-free injection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Ketamine products manufacturer PharmaTher Holdings Ltd. (OTCQB: PHRRF) had lots happening this past week. Here are the company's top three news items. FDA’s Orphan Drug Status To Ketamine For Rett ...
- Revive Therapeutics enters into research collaboration agreement with PharmaTher to develop MDMA transdermal patch
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said it has entered into a research collaboration agreement with PharmaTher Holdings Ltd to evaluate the delivery of 3,4-Methylenedioxy methamphetamine ...
- Revive Therapeutics Enters Into Research Collaboration Agreement With Pharmather For Development Of MDMA Transdermal Patch
Michael Frank, CEO of the Company, commented, 'We are excited about the potential of the MDMA microneedle patch, which will complement our psilocybin programs for mental health and abuse disorders. We ...
- Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for ...
TORONTO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...
- According to Microneedle Patch Market 2023 [Latest Report] | Growing Very High Prediction up to 2027 | 118 Pages Report
The MarketWatch News Department was not involved in the creation of this content. Feb 02, 2023 (The Expresswire) -- The Microneedle Patch Market (2023-2027) Research | Updated New Report | Market is ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”microneedle patches” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]